INTRODUCTION
Hemophagocytic lymphohistiocytosis (HLH), also known as hemophagocytic syndrome (HPS), is an uncommon, life-threatening, hyperinflammatory immunological disorder that is characterized by prolonged high fever, hyperlipidemia, hepatosplenomegaly and hemophagocytosis of bone marrow cells 1 . TCR alpha beta + CD3 + CD4 − CD8 − "double negative" (αβ DN) T cells comprise a small subset of mature peripheral T cells. While DN T cells constitute a rare and heterogeneous T cell subpopulation in healthy individuals, numbers of TCRαβ + DN T cells are expanded in several inflammatory conditions and may be involved in systemic inflammation and tissue damage as in disorders like SLE, Sjogren's syndrome, and psoriasis. 2 The expansion of these cells in peripheral blood and lymphoid tissues of patients with autoimmune lymphoproliferative syndrome (ALPS) is a consistent feature and is one of the diagnostic criteria of ALPS. 3 Mild elevations of these cells in several autoimmune diseases suggest that αβ DNTs may perhaps be more common among immune disorders and that these disorders may share a common pathway for immune dysregulation and immune dysfunction. 4 We sought to investigate the expression of αβ DN T cells in a group of pediatric patients with hemophagocytic syndrome. The ultimate objective is to anticipate the possible relation to HLH activity and/or severity. Erythrocyte sedimentation rate (ESR) was measured by Westergren method. We also measured serum alanine transaminase (ALT), aspartate transaminase (AST), serum albumin, serum lactate dehydrogenase (LDH) and triglycerides (fasting for 10 hours) using NADH, Kinetic UV, IFCC rec, Spinreact Kit using Cobas (Roche, Germany). Serum concentration of fibrinogen (g/L) was measured by p-Nitrophenyl phosphate, Kinetic, DGKC, Spinreact Kit using a coagulameter (DADE Behring, USA). Serum ferritin (ng/mL) was measured using a coagulameter (Au680, Bechman Coulter, USA).
• Flowcytometric measurement of alpha beta double negative (αβ DN) T cells was done using EPICS XL flow cytometer (Beckman Coulter Inc, California, USA). αβ DN T cells were measured among patients' group at enrollment and by week 9 from the start of HLH induction therapy among survivors and were also measured among controls. Counts ≥ 2 % of T cells were considered elevated.
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Statistical Methods: Data were analyzed using IBM SPSS Statistics version 23 (IBM Corp., Armonk, NY, USA), MedCalc version 15 (MedCalc Software BVBA, Ostend, Belgium). Normality of numerical data distribution was examined using the D'AgostinoPearson test. Non-normally distributed numerical variables were presented as median and interquartile range and between-group differences were compared using the Mann-Whitney test. Paired numerical data were compared using the Wilcoxon signed ranks test. Categorical variables were presented as number and percentage and intergroup differences were compared using Fisher's exact test. Ordinal data were compared using the chi-squared test for trend. Receiveroperating characteristic (ROC) curve analysis was used to examine the value of αβ DN T-cells for discrimination between cases and controls, and for prediction of mortality among cases in active disease. A p value <0.05 was considered significant.
RESULTS
Ages of the enrolled patients ranged from 6 months to 13 years with mean±SD values of 4.4±3.6 years. They were 14 males (56%) and 11 females (44%) with mean age at disease onset of 3.5 years. In 17 patients, infection was the trigger of HLH, while it was malignancy in three (non-Hodgkin lymphoma in 2 patients and acute lymphoblastic leukemia in one patient), rheumatological disorders in two (juvenile idiopathic arthritis) and immune deficiency in three (Chediak-Higashi syndrome, Griscelli syndrome and severe combined immunodeficiency). Clinico-demographic and laboratory abnormalities of enrolled patients are depicted in 
DISCUSSION
Infection was the most common trigger among our patients diagnosed with HLH. This observation agrees with what has been previously reported that infection, especially viral, is the most common trigger of HLH activity and this applies to primary 8 and secondary HLH forms. 9, 10 Common viruses in this domain include Epstein-Barr virus, cytomegalovirus and herpes simplex virus. 11 Also, other infections like fungal, parasitic or bacterial infections, including tuberculosis can trigger HLH activity. 12 In the current study, immune deficiency was detected in three patients with Chediak-Higashi syndrome, Griscelli syndrome and severe combined immunodeficiency. None of these children survived through the study period despite receiving treatment. HLH with primary immunodeficiency has been characterized by poor prognosis requiring rapid clinical and genetic diagnosis of the PID as well as initiation of appropriate management, including allogeneic hematopoietic stem cell transplantation. 13 Among our series, two patients had rheumatological diseases as a trigger for HLH. HLH secondary to rheumatological illness is usually termed macrophage activation syndrome (MAS). MAS could be fatal and complicate various pediatric autoimmune diseases especially systemic juvenile idiopathic arthritis (SOJIA) and systemic lupus erythematosus (SLE). MAS tends to occur in the setting of active underlying disease. [14] [15] [16] . αβ DN T cell percentages were significantly elevated among our HLH patients with a median value of 1.7% compared to controls (value). In addition, αβ DN T cells percentage was elevated in 15 patients with levels >2% of CD3+ T cells. These observations need to be further validated using molecular studies and cell cultures with cytokines assay. It may emphasize that mild elevation of αβ DN T cells is not specific for ALPS and should be interpreted cautiously even in presence of lymphoproliferation.
αβ DN T cells are legitimate components of the normal immune system that normally do not exceed 2% of T cells. Fas-mediated apoptosis actively removes normally existing αβ DN T cells from the periphery while impaired Fas-mediated apoptosis leads to accumulation of these cells, manifesting as lymphoproliferation.
Both regulatory and pathogenic functions have been attributed to αβ DN T cells. The excessive activation of CD8+ T lymphocytes and macrophages in HLH leads to chronic stimulation of CD8+ cytotoxic lymphocytes and the release of cytokines. 17 Although there is no direct and reproducible evidence for this concept, yet it might explain the link between the HLH uncontrolled inflammation and the mild increase in αβ DN T cells.
In support of the above findings, Abolghasemi et al. (2015), reported a 14-years old boy with HLH diagnosis who had elevated αβ DN T cells and normal level of vitamin B12. A diagnosis of HLH was considered since he met five of 8 criteria including pancytopenia, >38.5 °C fever, splenomegaly, hyperferritinemia and hypofibrinogenemia. Treatment of HLH was initiated according to the HLH-2004 protocol. The authors also noted that the patient's spleen had atypical Tcell hyperplasia with αβ DN T cells, consistent with the diagnosis of ALPS. He was then treated with prednisone and azathioprine which led him into remission. 18 HLH is known to have a high mortality rate whether primary or secondary. In Japan, among 57 HLH patients who underwent HSCT, survival rate was 65.0% for FHL and 85.7% for EBV-HLH. 19, 13 Another cohort study on 116 HLH Chinese children (mean age at diagnosis 27.5 months), had a fatality rate of 26 %, half of them died in the first 30 days of diagnosis. 20 We revaluated our patients by week 9 of HLH induction therapy in the 8 children who survived through the study and observed that the median αβ DN T percentages were significantly lower compared to initial levels (p=0.018), indicating a possible correlation of these cells to the degree of inflammation. αβ DN T cells had been described to be one of the major producers of IL-17, a well-known proinflammatory cytokine, 21 which may indicate a pathogenic role for αβ DN T cells. El-Sayed et al 22 in their prospective study which included 21 female patients with juvenile SLE (10-17 years old) found that the αβ DN T cells percentage values correlate with SLE disease activity. 22 Steroid therapy was reported to induce a significant decrease in the number and proportion of αβ DN T cells. 23 Initial αβ DN T cell percentages were comparable among survivors and non-survivors in our series. To the best of our knowledge, no previous studies addressed the relation between αβ DN T cells and HLH activity or prognosis. However, αβ DN T cells are reported to have prognostic value in other disorders. Licciardi et al 24 in their study on 39 patients with oligoarticular JIA, reported that low synovial αβ DN T cells (<1.8%) at disease onset is linked to longer free-disease survival. Also, their patients who relapsed during the follow-up showed higher αβ DN T cells at diagnosis as compared with non-relapsed patients.
Detailed comparison between survivors and nonsurvivors in our study revealed comparable clinical and laboratory data except for initial platelet counts which were significantly lower among survivors. This finding is indeed limited by the sample size and might point to the presence of other poor prognostic parameters in the non-survivors including poor adherence to treatment or influence of the original disease. Although, low platelet count was described as a poor prognostic factor associated with high mortality in several studies, [25] [26] [27] Oto et al 28 in their study on 34 children with HLH, denied any relation between the platelet count and HLH prognosis.
In conclusion, this pilot study denoted mild αβ DN T cell elevation in HLH patients that was associated with HLH activity and to some extent with severity. This may denote that αβ DN T cell overexpression is not ALPS specific. Our conclusions are indeed limited by the sample size and short follow up duration. Also, the consecutive enrollment of the sample led to uneven distribution of patients according to HLH triggers and this can hinder the power of analysis. Further wider scale studies may increase our insight into this condition. Also, an investigation at the molecular level could be more informative in terms of elucidating the relation between ALPS and HLH.
